Management

  • Douglas L. Drysdale
    Chairman, President and Chief Executive Officer
    Mr. Drysdale served as Chief Executive Officer of Alvogen, Inc., from 2008 to 2013, building the company from inception to become a global leader in pharmaceuticals. Alvogen now operates in thirty countries and has...
  • Terence Novak
    Chief Operating Officer
    Mr. Novak most recently served as President of Norwich Pharma Services where he established the company as a leader in the contract development and manufacturing industry focused on specialty pharmaceutical companies. Mr. Novak brings over 30 years...
  • Sanjay Patel
    Chief Financial Officer
    Mr. Patel brings to Pernix over 15 years of investment banking, institutional investment and public policy experience. Mr. Patel has assisted specialty pharmaceutical and healthcare companies raise more than $7 billion in initial public offerings, follow-on...
  • Rick Shalaby
    Senior Vice President of Commercial Operations
    Mr. Shalaby brings over twenty-three years of successful industry experience, including ten in executive leadership, to Pernix. His unique combination of big pharma, service provider and start-up pharmaceutical company experience combined with his motivational...
  • Barry J. Siegel
    Senior Vice President and General Counsel
    Mr. Siegel has 25 years experience practicing corporate and securities law. From February 2011 to May 2014 he was a Shareholder and Co-Chair of the Private Equity Practice Group of Buchanan Ingersoll & Rooney PC....
  • Tracy S. Clifford
    Principal Accounting Officer and Corporate Controller
    From December 2011 to March 2013, Ms. Clifford served as Corporate Controller and Director of Finance of the Company. Ms. Clifford has served as Secretary and Treasurer of the Company since the merger...